NEXT
Sign in to follow
Search Results

0 results for 'Brown Rudnick LLP'

You can use to get even better search results
April 21, 2017 |

McGuireWoods Swaps Lobby Leaders, DLA Piper Lures Litigators, John Grisham Comes to DC

McGuireWoods is entering a time of transition, with the firm this week naming new management at its McGuireWoods Consulting business, effective in January. Expect change in the law firm's leadership in the near future, too.
69 minute read
April 21, 2017 | National Law Journal

McGuireWoods Swaps Lobby Leaders, DLA Piper Lures Litigators, John Grisham Comes to DC

McGuireWoods is entering a time of transition, with the firm this week naming new management at its McGuireWoods Consulting business, effective in January. Expect change in the law firm's leadership in the near future, too.
70 minute read
April 19, 2017 |

DLA Piper Hires Hogan Lovells China IP Partner

William “Skip” Fisher will be China head of patent at his new firm and remains in Shanghai.
22 minute read
April 19, 2017 |

DLA Piper Hires Hogan Lovells China IP Partner

William “Skip” Fisher will be China head of patent at his new firm and remains in Shanghai.
22 minute read
April 18, 2017 |

Supreme Court May Clip SEC's Enforcement Power

A case argued Tuesday considers whether the use of "disgorgement" by the U.S. Securities and Exchange Commission should be considered a penalty subject to a five-year statute of limitations.
7 minute read
April 18, 2017 | National Law Journal

Supreme Court May Clip SEC's Enforcement Power

A case argued Tuesday considers whether the use of "disgorgement" by the U.S. Securities and Exchange Commission should be considered a penalty subject to a five-year statute of limitations.
7 minute read
April 14, 2017 |

Pfizer Fails Second Bid to Escape Whistleblower Suit

After two attempts to get out of a whistleblower case, Pfizer is still on the hook for claims that it illegally marketed an anti-fungal medication, Vfend, for off-label use.
9 minute read
April 14, 2017 | The Legal Intelligencer

Pfizer Fails Second Bid to Escape Whistleblower Suit

After two attempts to get out of a whistleblower case, Pfizer is still on the hook for claims that it illegally marketed an anti-fungal medication, Vfend, for off-label use.
9 minute read
April 14, 2017 |

Porzio Rises in DC, Firms Get New In-Town Leaders, Trump Settlements Pile Up

Washington Wrap is a weekly roundup of Big Law hires and other Washington, D.C., legal industry news.
56 minute read
April 07, 2017 |

Merger Mania Continues, But NJ Firms Stay Quiet

Law firm merger activity remained high in the first quarter of 2017, but New Jersey firms sat out the action.
37 minute read

More from ALM

More from ALM

Legal Speak is a weekly podcast that makes sense of what’s happening in the legal industry.

Resources

  • Blueprint for Successful Second Request Document Review

    Brought to you by Integreon

    Download Now

  • Employee Happiness Playbook: The 3 R's for Business Success in 2024

    Brought to you by Amazing Workplace, Inc.

    Download Now

  • The Positive Impact of AI at Small Law Firms: 4 Key Insights

    Brought to you by LexisNexis®

    Download Now

  • Will Generative AIs Transform Legal Services? Defensibility and Security Must Be a Focus

    Brought to you by HaystackID

    Download Now